A contamination-free electrolyte-gated organic transistors platform for high-accuracy tumor biomarker detection

Abstract

A novel biosensor platform for high-accuracy tumor biomarker detection exploiting contamination free microfluidics for increasing the signal-to-noise ratio has been successfully developed and tested. Electrolyte-gated organic Transistors (EGOT) has been employed to detect an important tumor marker, Angiopoietin-2 (Ang2). Although organic semiconductors have become popular in the last years in biosensing applications due to their many advantages, there is still a main concern about stability and selectivity. This work presents major improvement in terms of the stability and selective detection of Ang2 in the range of interest for biomedical applications. The semiconducting polymer poly[3-(5-carboxypentyl)thiophene (P3CPT) is deposited by picoliter volume control and micrometer diameter of the droplet to allow for high uniformity and repeatability from sample to sample. The optimized gold electrodes improve the detection of the minimal concentration of the target and microfluidic interfacing by a specific pattern with the desired dimensions is obtained by UV-lithography and wet etching. A microfluidics with multiple flow control allows for maintain a constant fresh solution without analytes on reference gate electrode, while another inlet and functionalized gate is used for sensing, thus reaching high stability and reproducibility. All these (four) optimizations lead to new measuring protocol and new 3D printed top cover that ensure better stabilization and repeatability of the results. The device has successfully detected Ang2 concentrations as low as 10 pM in saline, therefore demonstrating the ability of the device to detect clinically relevant concentrations.